A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia
NCT02669030
Recruiting
Depression with ongoing insomnia is a common clinical presentation with patients. Clinical data suggests that patients with insomnia that receive concomitant treatment with a sleep aid experience a more robust antidepressant response along with a quicker response. The purpose of this clinical study is to compare the effectiveness of the FDA-approved insomnia medication suvorexant, also known as Belsomra®, as add-on treatment to an antidepressant to that of placebo plus antidepressant treatment i... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Locations: Medical College of GA at Augusta Univeristy, Augusta, Georgia +1 locations
Conditions: Depression, Major Depressive Disorder, MDD, Insomnia
Register for Updates